{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:48:13Z","timestamp":1791276493535,"version":"4.1.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1097\/md.0000000000001000","type":"journal-article","created":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T10:31:41Z","timestamp":1434709901000},"page":"e1000","source":"Crossref","is-referenced-by-count":92,"title":["Eculizumab in Typical Hemolytic Uremic Syndrome (HUS) With Neurological Involvement"],"prefix":"10.1097","volume":"94","author":[{"given":"Lars","family":"Pape","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz Christoph","family":"Bange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Suerbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Bueltmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thurid","family":"Ahlenstiel-Grunow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-36-20210226","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ijmm.2005.06.009","article-title":"Enterohaemorrhagic Escherichia coli in human medicine.","volume":"295","author":"Karch","year":"2005","journal-title":"Int J Med Microbiol"},{"key":"R2-36-20210226","first-page":"905","article-title":"Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia.","volume":"85","author":"Gasser","year":"1955","journal-title":"Schweiz Med Wochenschr"},{"key":"R3-36-20210226","first-page":"1073","article-title":"Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.","volume":"365","author":"Tarr","year":"2005","journal-title":"Lancet"},{"key":"R4-36-20210226","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nrneph.2012.196","article-title":"Renal and neurological involvement in typical Shiga toxin-associated HUS.","volume":"8","author":"Trachtman","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"R5-36-20210226","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0140-6736(10)60963-4","article-title":"Escherichia coli O157.","volume":"376","author":"Pennington","year":"2010","journal-title":"Lancet"},{"key":"R6-36-20210226","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00431-009-1039-4","article-title":"Clinical practice. Todays understanding of the haemolytic uraemic syndrome.","volume":"169","author":"Scheiring","year":"2010","journal-title":"Eur J Pediatr"},{"key":"R7-36-20210226","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/adc.84.5.434","article-title":"Acute neurology and neurophysiology of haemolytic-uraemic syndrome.","volume":"84","author":"Eriksson","year":"2001","journal-title":"Arch Dis Child"},{"key":"R8-36-20210226","first-page":"694","article-title":"Short-term and long-term outcome of hemolytic uremic syndrome in Iranian children.","volume":"21","author":"Otukesh","year":"2008","journal-title":"J Nephrol"},{"key":"R9-36-20210226","first-page":"67","article-title":"Clinical and pathologic aspects of central nervous system involvement in the haemolytic uraemic syndrome.","volume":"8","author":"Rooney","year":"1971","journal-title":"Proc Aust Assoc Neurol"},{"key":"R10-36-20210226","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ana.410190120","article-title":"Neurological involvement in hemolytic-uremic syndrome.","volume":"19","author":"Sheth","year":"1986","journal-title":"Ann Neurol"},{"key":"R11-36-20210226","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/adc.80.3.214","article-title":"Neuropsychological sequelae of haemolytic uraemic syndrome. Investigators of the HUS Cognitive Study.","volume":"80","author":"Schlieper","year":"1999","journal-title":"Arch Dis Child"},{"key":"R12-36-20210226","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/088307388900400206","article-title":"Neurological complications of hemolytic-uremic syndrome.","volume":"4","author":"Hahn","year":"1989","journal-title":"J Child Neurol"},{"key":"R13-36-20210226","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2215\/CJN.08921209","article-title":"Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome.","volume":"5","author":"Nathanson","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R14-36-20210226","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.4049\/jimmunol.0900151","article-title":"Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome.","volume":"182","author":"Orth","year":"2009","journal-title":"J Immunol"},{"key":"R15-36-20210226","first-page":"675","article-title":"Atypical HUS: time to take stock of current guidelines and outcome measures Pediatr N","volume":"28","author":"Rees","year":"2013","journal-title":"ephrol"},{"key":"R16-36-20210226","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1056\/NEJMc1100859","article-title":"Eculizumab in severe Shiga-toxin-associated HUS.","volume":"364","author":"Lapeyraque","year":"2011","journal-title":"N Engl J Med"},{"key":"R17-36-20210226","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00467-014-2803-x","article-title":"Neurological involvement in children with E. coli O104:H4-induced hemolytic uremic syndrome.","volume":"29","author":"Bauer","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"R19-36-20210226","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/dmcn.12161","article-title":"Brain magnetic resonance imaging pattern and outcome in children with haemolytic-uraemic syndrome and neurological impairment treated with eculizumab.","volume":"55","author":"Gitiaux","year":"2013","journal-title":"Dev Med Child Neurol"},{"key":"R20-36-20210226","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s00330-011-2286-0","article-title":"Patterns in early diffusion-weighted MRI in children with haemolytic uraemic syndrome and CNS involvement.","volume":"22","author":"Donnerstag","year":"2012","journal-title":"Eur Radiol"},{"key":"R21-36-20210226","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1093\/ndt\/gfs394","article-title":"Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry.","volume":"27","author":"Kielstein","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R22-36-20210226","first-page":"S3","article-title":"Central nervous system involvement in hemolytic uremic syndrome (HUS): a retrospective analysis of cerebral CT and MRI studies.","volume":"56","author":"Theobald","year":"2001","journal-title":"Clin Nephrol"},{"key":"R23-36-20210226","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.2215\/CJN.02730409","article-title":"Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome.","volume":"4","author":"Thurman","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R24-36-20210226","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF00858990","article-title":"Extrarenal involvement in diarrhoea-associated haemolytic-uraemic syndrome.","volume":"9","author":"Gallo","year":"1995","journal-title":"Pediatr Nephrol"},{"key":"R25-36-20210226","first-page":"105","article-title":"Deficiencies and excessive human complement system activation in disorders of multifarious etiology.","volume":"21","author":"Tichaczek-Goska","year":"2012","journal-title":"Adv Clin Exp Med"},{"key":"R26-36-20210226","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s10875-013-9872-7","article-title":"C5 complement deficiency in a Saudi family, molecular characterization of mutation and literature review.","volume":"33","author":"Arnaout","year":"2013","journal-title":"J Clin Immunol"},{"key":"R27-36-20210226","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/bjh.12347","article-title":"Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria.","volume":"162","author":"Hillmen","year":"2013","journal-title":"Br J Haematol"},{"key":"R28-36-20210226","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3201\/eid1804.111310","article-title":"Shiga toxin-producing Escherichia coli serotype O78:H(-) in family, Finland, 2009.","volume":"18","author":"Lienemann","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"R29-36-20210226","doi-asserted-by":"crossref","first-page":"e4565","DOI":"10.1136\/bmj.e4565","article-title":"Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study.","volume":"345","author":"Menne","year":"2012","journal-title":"BMJ"},{"key":"R30-36-20210226","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1473-3099(11)70165-7","article-title":"Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study.","volume":"11","author":"Bielaszewska","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"R31-36-20210226","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/cid\/cis1218","article-title":"Duration of fecal shedding of Shiga toxin-producing Escherichia coli O104:H4 in patients infected during the 2011 outbreak in Germany: a multicenter study.","volume":"56","author":"Vonberg","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R32-36-20210226","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00103-012-1577-1","article-title":"Management of patients with EHECHUS. Lessons and perspectives from clinical infectious disease specialists. Article in German.","volume":"56","author":"Kern","year":"2013","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000001000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T16:17:34Z","timestamp":1717949854000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201506030-00036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":31,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000001000","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}